Robert J. Gould

Robert J. Gould

DirectoratFulcrum Therapeutics· In proxies 2022–2025

Pay in FY2023+259% from the year before · Fulcrum Therapeutics stock -7.3% the same year

Robert J. Gould was paid $424.5K in FY2023 (Dec), up 259%. Fulcrum Therapeutics stock fell 7.3% that year.

Pay$100 in the stock at the end of FY21 → $38
Pay is from the Summary Compensation Table of each Fulcrum Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Fulcrum TherapeuticsPublic company · 4 yr
    • Director2022 – Present · 4 yrStock in role -79%
  2. TurnstonePublic company
    • Director? – PresentNo stock prices for these years
  3. Turnstone Biologics CorpPublic company · 6 yr
    • Director2019 – 2025 · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?